The tobacco industry giant, Altria Group, has witnessed a period of volatile stock performance in recent years. While shareholders have welcomed periods of growth, the firm's future prospects remain a topic of debate. Factors impacting Altria Group's stock performance include governmental actions, market preferences, and the overall health of the t

The FDA has issued a warning about the risks of smuggled tirzepatide as the peptide therapeutics market grows rapidly. The market is expected to jump from $38 billion in 2023 to $106 billion by 2033, with an impressive 10.8% compound annual growth rate. Legitimate peptide medications have revolutionized modern medicine, with 102 FDA-approved therap